Where to buy Acotiamide

Acotiamide is a drug that has gradually attracted attention in the field of functional dyspepsia (FD) in recent years. Its main mechanism of action is to relieve symptoms such as postprandial fullness, upper abdominal discomfort, and early satiety in patients by enhancing gastrointestinal motility, improving gastric emptying, and alleviating gastric motility. Unlike traditional prokinetic drugs, acotiamide does not simply stimulate gastrointestinal contraction, but helps restore the normal physiological rhythm of the stomach by regulating neurotransmitter release and improving gastrointestinal smooth muscle activity. Therefore, it has certain advantages in terms of tolerance and long-term safety.

Functional dyspepsia is a common but complex gastrointestinal disease. Patients often have no obvious organic disease during gastroscopy, B-ultrasound and other examinations, but suffer from long-term indigestion symptoms, which affects their quality of life. In this context, acotiamide, as an innovative treatment method, fills the gap of long-term lack of effective drugs for some patients.

In terms of drug purchase channels, the original drug of acotiamide has not yet been launched in mainland China, so it cannot be purchased directly in ordinary domestic pharmacies and hospitals for the time being. At present, if domestic patients need to use it, they often need to obtain it through formal cross-border medical channels or overseas drug purchase. The drug has been marketed in countries such as Japan and Russia, and the Japanese version is commonly available in 100mg*100 tablets. Patients should be cautious when choosing and try to purchase through professional medical institutions or reliable channels.

In summary, acotiamide has broad application prospects and is especially suitable for patients who have long been troubled by functional dyspepsia. However, as it has not yet been launched in the country, special attention must be paid to channel compliance and medication safety when obtaining the drug. With the acceleration of the introduction of international drugs, acotiamide is expected to gradually enter the domestic market in the future, benefiting more patients.

Reference: https://www.rad-ar.or.jp/siori/english/search/result?n=33322